As a tumor inhibitor in the early stage of CC, TGF-β1 can downregulate expression proliferative drivers such as c-Myc and upregulate expression of p27Kip1 protein [70], and it can activate p53 expression and Rb response pathway, and induce cellular senescence in CC cells [71]. The gene discussed is MYC; the disease is neoplasm.